Gallic Acid

Gallic Acid

SCHEMBL2589994

O=C([O-])c1cc(O)c(O)c(O)c1.[K+]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Gallic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.56
▸ LMNA P02545 3/20 0.56
▸ TDP1 Q9NUW8 3/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ MAPT P10636 2/20 0.56
▸ FUT7 Q11130 2/20 0.56
▸ CA1 P00915 2/20 0.56
▸ CA2 P00918 2/20 0.56
▸ CA12 O43570 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ CA3 P07451 1/20 0.56
▸ SELL P14151 1/20 0.56
▸ HPGD P15428 1/20 0.56
▸ SELP P16109 1/20 0.56
▸ FUT4 P22083 1/20 0.56
▸ CA4 P22748 1/20 0.56
▸ CA6 P23280 1/20 0.56
▸ DPP4 P27487 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ CA5A P35218 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gallic Acid SCHEMBL4276877 0.97 KDM4E (0.54) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL8649680 0.97 KDM4E (0.54) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL4276882 0.97 KDM4E (0.54) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL8649681 0.97 KDM4E (0.54) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL28654164 0.97 KDM4E (0.59) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL15529595 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL2517500 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL338355 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL21273262 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL21273260 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118146483-A Flame-retardant low-smoke-toxicity polyurethane foam material and preparation method thereof 西华大学 2024-06-07 — — CN claimed
CN-113862484-B Method for efficiently extracting gallium from brown fused alumina smoke dust 武汉科技大学 2023-07-18 — — CN claimed
CN-116262146-A Bone healing and growth material 苏基萨姆知识产权管理私人有限公司 2023-06-16 — — CN claimed
CN-113604206-B Temporary plugging agent for oily sludge and preparation method thereof 中国石油天然气股份有限公司 2023-01-10 — — CN claimed
CN-114672068-A Intumescent flame retardant for polyurethane, flame-retardant polyurethane and preparation of flame-retardant polyurethane 四川大学 2022-06-28 — — CN claimed
CN-109678801-B Benzene hydroxyl anion functionalized ionic liquid antioxidant and preparation method thereof 昆明理工大学 2022-05-06 — — CN claimed
CN-113604206-A Temporary plugging agent for oily sludge and preparation method thereof 中国石油天然气股份有限公司 2021-11-05 — — CN claimed
US-6426112-B1 GENETIC ENGINEERED UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2002-07-30 — — US claimed
EP-0688738-B1 A gallium silicate having 12-ring pores (ECR-34) and a method for its preparation EXXON RESEARCH ENGINEERING CO (US) 1998-09-16 — — EP claimed
EP-0688738-A2 A gallium silicate having 12-ring pores (ECR-34) and a method for its preparation EXXON RESEARCH AND ENGINEERING COMPANY (US) 1995-12-27 — — EP claimed
US-4460674-A GALLIC ACID DERIVATIVES AND NAPOHTHOQUINONES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-07-17 — — US claimed
US-12559377-B2 Method of synthesizing a molecular sieve of MWW framework type EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-02-24 — — US disclosed
US-20260048993-A1 METHOD OF MAKING MOLECULAR SIEVES OF DON FRAMEWORK TYPE EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2026-02-19 — — US disclosed
EP-4676883-A1 EMM-74 MOLECULAR SIEVE COMPOSITIONS, SYNTHESES, AND USES ExxonMobil Technology and Engineering Company (US) 2026-01-14 — — EP disclosed
EP-4660136-A2 USE OF 1-METHYL-6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDINE-1-IUM CATION AS STRUCTURE DIRECTING AGENT FOR THE PREPARATION OF EMM-64 ExxonMobil Technology and Engineering Company (US) 2025-12-10 — — EP disclosed
US-4725414-A Process for producing gallium-containing solution from aluminum smelting dust MITSUI ALUMINIUM CO., LTD. (JP) 1988-02-16 — — US disclosed
US-4460674-A GALLIC ACID DERIVATIVES AND NAPOHTHOQUINONES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-07-17 — — US disclosed
US-4218520-A Apparatus for generating heat and electrical energy from aluminum waste and other inexpensive aluminum products ALUMINUM COMPANY OF AMERICA 1980-08-19 — — US disclosed
US-4198475-A ELECTROLYTIC CELLS REYNOLDS METALS COMPANY (US) 1980-04-15 — — US disclosed
US-4150197-A Methods for generating heat and electrical energy from aluminum waste and other inexpensive aluminum products ALUMINUM COMPANY OF AMERICA 1979-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260048993-A1 METHOD OF MAKING MOLECULAR SIEVES OF DON FRAMEWORK TYPE APP, HCN4, BACE1 KDM4E 759/4885LMNA 146/4885TDP1 1200/4885
US-12559377-B2 Method of synthesizing a molecular sieve of MWW framework type SIK1, SIK2, KCNK9 KDM4E 1374/4885LMNA 2417/4885TDP1 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback